Sharp, part of UDG Healthcare, has appointed Ria Rhemrev-Boom as its new lead EU Qualified Person (QP) for market release services.
In her new role, Rhemrev-Boom will take responsibility for leading Sharp’s QP release to market services for its customers, ensuring the medicines manufactured, packaged and handled throughout the supply chain comply with EU GMP rules and all applicable regulatory standards.
Rhemrev-Boom has a PhD in Medical Science from the University of Groningen and has worked across a number of key roles in the pharma and biotechnology industry in a career spanning over 35 years, including R&D manager, Lab Director and CEO for a variety of service organizations. She has extensive experience in delivering QP services and implementing quality management systems (QMS).
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!
“Ria’s appointment is a key part of Sharp’s strategy of ensuring we offer a full suite of services for our customers. This will be particularly important to biotech manufacturers and virtual businesses as they often require support in the EU in relation to the release of their products onto the market,” Robert O’Beirn, Managing Director of Sharp Europe, said. “She will be instrumental in helping to streamline the journey of our customers’ products to market in the EU and will further enhance the strong quality culture in the Sharp EU organization, led by Chris Bruyninckx, QA/RA Manager of Sharp Europe.”